MUC1 and acute respiratory distress syndrome: Before these markers can by implemented in routine clinical practice, not only additional information on alveolar type II cells and SP-D and KL-6 production in ALI/ARDS patients is needed but also a study comparing the use of biomarkers with current clinical ALI/ARDS scores as the LIS and NAECC criteria.